{"transactions":[{"id":740719,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39035,"kind":"person","name":"Donnelly Brian J","position":1,"cik":"0002065630","reported_name":"Donnelly Brian J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Common Stock","published_at":"2026-06-12T22:05:58.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":3.936,"value":19680.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":573363,"source":{"system":"sec-edgar","filing":"0002065630-26-000006","document":"wk-form4_1781301956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000206563026000006/wk-form4_1781301956.xml","form_type":"4"}},{"id":794507,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39035,"kind":"person","name":"Donnelly Brian J","position":1,"cik":"0002065630","reported_name":"Donnelly Brian J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Common Stock","published_at":"2026-05-04T20:35:41.000Z","date":"2026-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":55975,"price":4.8,"value":268680.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on May 1, 2026."}],"balance_after":568363,"source":{"system":"sec-edgar","filing":"0002065630-26-000004","document":"wk-form4_1777926939.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000206563026000004/wk-form4_1777926939.xml","form_type":"4"}},{"id":842661,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39035,"kind":"person","name":"Donnelly Brian J","position":1,"cik":"0002065630","reported_name":"Donnelly Brian J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:46.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":226804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":624338,"source":{"system":"sec-edgar","filing":"0002065630-26-000002","document":"wk-form4_1773695144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000206563026000002/wk-form4_1773695144.xml","form_type":"4"}},{"id":1161751,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39035,"kind":"person","name":"Donnelly Brian J","position":1,"cik":"0002065630","reported_name":"Donnelly Brian J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2025-05-02T20:15:16.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":236167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than May 1, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than May 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than May 1, 2026."}],"balance_after":236167,"derivative":{"underlying":"Common Stock","underlying_shares":236167},"source":{"system":"sec-edgar","filing":"0002065630-25-000004","document":"wk-form4_1746216907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000206563025000004/wk-form4_1746216907.xml","form_type":"4"}},{"id":1161750,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39035,"kind":"person","name":"Donnelly Brian J","position":1,"cik":"0002065630","reported_name":"Donnelly Brian J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Common Stock","published_at":"2025-05-02T20:15:16.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":127629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":397534,"source":{"system":"sec-edgar","filing":"0002065630-25-000004","document":"wk-form4_1746216907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000206563025000004/wk-form4_1746216907.xml","form_type":"4"}},{"id":1161749,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39035,"kind":"person","name":"Donnelly Brian J","position":1,"cik":"0002065630","reported_name":"Donnelly Brian J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Common Stock","published_at":"2025-05-02T20:15:16.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":269905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":269905,"source":{"system":"sec-edgar","filing":"0002065630-25-000004","document":"wk-form4_1746216907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000206563025000004/wk-form4_1746216907.xml","form_type":"4"}}]}